Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiny Health offers at-home gut and vaginal microbiome tests for families—especially mothers and babies aged 0–3 years—to detect imbalances early and provide evidence-based action plans. Their CLIA/CAP-certified lab uses shotgun metagenomic sequencing with strain-level resolution to analyze over 120,000 microbes per sample. Results are delivered via a proprietary bioinformatics pipeline that generates personalized reports and recommendations. The company’s focus is on prevention of chronic childhood conditions through early-life microbiome optimization. They also offer a B2B/co-branded testing/data analytics platform for partners in clinical research or wellness programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tiny Health.